Leadership & Pay ·
AstraZeneca PLC disclosed that Chief Executive Officer Pascal Soriot purchased 60,000 ordinary shares on September 14…
AZNAstrazeneca PLC
AstraZeneca PLC disclosed that Chief Executive Officer Pascal Soriot purchased 60,000 ordinary shares on September 14, 2026, at a price of £121.02 per share. This transaction was notified to the company on September 16, 2026, in compliance with EU Market Abuse Regulation requirements. AstraZeneca PLC is a global biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines.